XWXiaoyan Wu

Xiaoyan Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaoyan Wu has a total of 1 co-authors. Here are the top co-authors by number of shared publications:

  • Chun Hu

    Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan, China

    2 shared publications

Latest Publications

  • Effect of Vitamin D Supplementation on Vascular Function and Inflammation in Patients with Chronic Kidney Disease: A Controversial Issue

    by Chun Hu, Xiaoyan Wu

    Vitamin D deficiency is common in patients with CKD and is associated with vascular dysfunction and inflammation. In recent years, some randomized controlled trials have revealed the effect of vitamin D supplementation on vascular function and inflammation in CKD patients, but the results are inconsistent. Thus, in light of the controversy, we performed a systematic review and meta‐analysis of the effect of vitamin D in patients with CKD. We searched the literature in multiple databases for clinical trials from the date of inception to December 2018. The standardized mean difference (SMD) effect size was pooled using fixed and random effects models. A total of 10 randomized controlled trials involving 579 patients were included in the meta‐analysis; among these, 313 patients were treated with vitamin D, and the control group included 266 who received a placebo. This meta‐analysis revealed no statistical significance in the levels of flow‐mediated dilatation (SMD, 0.94; 95% CI, −0.33 to 2.21; P = 0.15); pulse wave velocity (SMD, −0.13; 95% CI, −0.38 to 0.13; P = 0.33); systolic BP (SMD, −0.04; 95% CI, −0.29 to 0.22; P = 0.77); diastolic BP (SMD, 0.01; 95% CI, −0.26 to 0.27; P = 0.97); and CRP (SMD, −0.09; 95% CI, −0.44 to 0.26; P = 0.61) between the vitamin D group and controls for patients with CKD. Short‐term intervention with vitamin D was not associated with improvements in vascular function and inflammation, as measured by flow‐mediated dilatation, pulse wave velocity, systolic BP, diastolic BP and CRP. This suggested that there is insufficient evidence to conclude the benefit of vitamin D supplementation on vascular function and inflammation in CKD patients.


  • Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue

    by Chun Hu, Xiaoyan Wu

    The prevalence of asymptomatic HUA is increasing year after year. HUA is a risk factor for the occurrence and development of renal diseases. However, the role of urate-lowering therapy in asymptomatic HUA complicated by renal damage is still controversial. In some experiments, the treatment of asymptomatic HUA complicated by renal damage may delay the progression of kidney damage. In addition, there is increasing evidence, suggesting that elevated serum uric acid is an independent risk factor for kidney disease. However, in other studies, uric acid-lowering therapy did not improve renal function, and uric acid levels could not be used as an independent predictor for CKD development. Further experimental studies are needed to determine the starting threshold and target value of asymptomatic HUA complicated by renal damage. At the same time, confirmation of the benefits of urate-lowering therapy for kidneys requires studies with larger samples and high-quality RCTs.